Zai Lab Limited ADR’s filing revealed that its Officer Du Ying acquired Company’s shares for reported $1.74 million on Aug 08 ’25. In the deal valued at $34.74 per share,50,000 shares were bought.
Then, Amado Rafael bought 3,000 shares, generating $105,000 in total proceeds.
Before that, Chen Yajing bought 4,096 shares. Zai Lab Limited ADR shares valued at $139,305 were divested by the Officer at a price of $34.01 per share.
Scotiabank initiated its Zai Lab Limited ADR [ZLAB] rating to a Sector outperform in a research note published on March 07, 2025; the price target was $55. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Morgan Stanley began covering ZLAB with “an Overweight” recommendation on December 14, 2023. Cantor Fitzgerald started covering the stock on August 10, 2023. It rated ZLAB as “an Overweight”.
Price Performance Review of ZLAB
On Friday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock jump 2.58% to $34.96. Over the last five days, the stock has lost -5.05%. Zai Lab Limited ADR shares have risen nearly 93.04% since the year began. Nevertheless, the stocks have risen 33.49% over the past one year.
How much short interest is there in Zai Lab Limited ADR?
A steep rise in short interest was recorded in Zai Lab Limited ADR stocks on 2025-07-15, dropping by -0.41 million shares to a total of 3.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.39 million shares. There was a decline of -10.21%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 21, 2022 when Macquarie began covering the stock and recommended ‘”an Outperform”‘ rating along with a $64 price target.
